Antithrombin protein to predict heparin resistance in heart surgery
Part of Heart & circulation clinical trials.
This study looks at whether a protein in your blood (antithrombin) can predict if you'll have trouble with the blood thinner heparin during heart surgery. If you qualify, it might help doctors personalize your care to reduce bleeding or clotting risks during and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be scheduled for heart surgery that uses a heart-lung machine.
- You must be able to give informed consent.
- Your surgery cannot be an emergency.
- You cannot be taking antithrombin supplements before surgery.
- You cannot have severe liver failure or a serious bleeding/clotting disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.
This study tests a new blood test that measures how well your blood forms clots. It aims to see if this test can predict bleeding after heart surgery that uses a heart-lung machine, which might help doctors manage bleeding better.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This study tests a blood-derived medicine (antithrombin) to help people who do not respond well to the blood thinner heparin during heart surgery. It aims to make surgery safer by improving blood thinning.
This study looks back at patient records to see how antithrombin (a medicine that helps prevent blood clots) was used in intensive care or during surgery. It does not test a new treatment, but helps doctors understand if the medicine was given appropriately.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.